Actinium Pharmaceuticals
ATNM
ATNM
72 hedge funds and large institutions have $15.9M invested in Actinium Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 73 → 72 (-1)
70% less capital invested
Capital invested by funds: $53.6M → $15.9M (-$37.7M)
Holders
72
Holding in Top 10
–
Calls
$170K
Puts
$41K
Top Buyers
| 1 | +$851K | |
| 2 | +$676K | |
| 3 | +$405K | |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
+$322K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$274K |
Top Sellers
| 1 | -$1.05M | |
| 2 | -$664K | |
| 3 | -$556K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$419K |
| 5 |
CCIA
Campbell & Co Investment Adviser
Baltimore,
Maryland
|
-$237K |